{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA090034"
        ],
        "brand_name": [
          "RIFAMPIN"
        ],
        "generic_name": [
          "RIFAMPIN"
        ],
        "manufacturer_name": [
          "Lupin Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68180-658",
          "68180-659"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "RIFAMPIN"
        ],
        "rxcui": [
          "198201",
          "198202"
        ],
        "spl_id": [
          "5ed1edac-e11e-4f87-b390-e770a69a9b37"
        ],
        "spl_set_id": [
          "b56004f0-f23d-47f6-80c7-39884fccbccc"
        ],
        "package_ndc": [
          "68180-658-06",
          "68180-658-01",
          "68180-659-06",
          "68180-659-07",
          "68180-659-01"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175500",
          "M0019113"
        ],
        "pharm_class_epc": [
          "Rifamycin Antibacterial [EPC]"
        ],
        "pharm_class_cs": [
          "Rifamycins [CS]"
        ],
        "unii": [
          "VJT6J7R4TR"
        ]
      },
      "product_type": "Drugs",
      "event_id": "91295",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "Harborplace Tower",
      "address_2": "111 S Calvert St Fl 21st",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide in the USA",
      "recall_number": "D-0100-2023",
      "product_description": "Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India. NDC 68180-659-06",
      "product_quantity": "16,056 30 count bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.",
      "recall_initiation_date": "20221212",
      "center_classification_date": "20230109",
      "termination_date": "20240131",
      "report_date": "20230118",
      "code_info": "Lot # A200171, Exp 12/2023",
      "more_code_info": ""
    }
  ]
}